Long-term dose optimization of adalimumab via dose spacing in patients with psoriasis
M Benzaquen, M Munshi, S Bossart, L Feldmeyer… - Bioengineering, 2022 - mdpi.com
… in psoriasis patients with low, stable disease activity. Although noninferiority regarding disease
activity was not demonstrated, DS of adalimumab, etanercept, … by a multicenter study [13]. …
activity was not demonstrated, DS of adalimumab, etanercept, … by a multicenter study [13]. …
Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
LS van Der Schoot, S Atalay, ME Otero… - British Journal of …, 2022 - academic.oup.com
… be a concern for patients and clinicians. Therefore, the aim of the current study was to evaluate
the … dose in patients who discontinued DR of adalimumab, etanercept or ustekinumab. …
the … dose in patients who discontinued DR of adalimumab, etanercept or ustekinumab. …
… (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
LS van der Schoot, JMPA van den Reek, L Grine… - Trials, 2021 - Springer
… psoriasis, we recently conducted a randomized non-inferiority trial on DR of adalimumab,
etanercept and ustekinumab in patients … Down-titration and discontinuation strategies of tumour …
etanercept and ustekinumab in patients … Down-titration and discontinuation strategies of tumour …
[PDF][PDF] Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
LS van der Schoota, S Atalaya… - … in psoriasis care, 2023 - repository.ubn.ru.nl
… Therefore, the aim of the current study was to evaluate the effectiveness of re-… Down-titration
of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study. Acta …
of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study. Acta …
Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
CAJ Michielsens, N den Broeder, MLM Mulder… - …, 2022 - academic.oup.com
… evidence, which predominantly consists of observational studies with no direct comparison
of tapered with non-tapered treatment, different patient selection (active disease at baseline) …
of tapered with non-tapered treatment, different patient selection (active disease at baseline) …
Cost-effectiveness of therapeutic drug monitoring-guided adalimumab therapy in rheumatic diseases: a prospective, pragmatic trial
C Gómez-Arango, I Gorostiza, E Úcar… - Rheumatology and …, 2021 - Springer
… with rheumatoid arthritis, psoriatic arthritis and ankylosing … confirms that adalimumab
down-titration in RA patients in remission, … A previous observational study suggested that …
down-titration in RA patients in remission, … A previous observational study suggested that …
[PDF][PDF] Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
CGAIG Eduardo, UMLGV Clara, E Pérez… - 2021 - academia.edu
… with rheumatoid arthritis, psoriatic arthritis and ankylosing … confirms that adalimumab
down-titration in RA patients in remission, … A previous observational study suggested that …
down-titration in RA patients in remission, … A previous observational study suggested that …
Dose tapering of biologic agents in patients with rheumatoid arthritis—results from a cohort study in Germany
D Krause, C Krause, H Rudolf, X Baraliakos… - Clinical …, 2021 - Springer
… and patient characteristics, we designed this observational study, … , dose reduction of
adalimumab or etanercept was non-inferior … showed that down-titration of biologics in RA patients …
adalimumab or etanercept was non-inferior … showed that down-titration of biologics in RA patients …
[PDF][PDF] Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide
LS van der Schoota, ME van Muijena… - … in psoriasis care, 2023 - repository.ubn.ru.nl
… biologics, several observational studies showed that DR of adalimumab, … Down-titration
of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study. Acta …
of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study. Acta …
Dose tapering of biologics in patients with psoriasis: a scoping review
CAJ Michielsens, ME Van Muijen, LM Verhoef… - Drugs, 2021 - Springer
… tapering in psoriasis patients: four randomized controlled trials and 15 observational studies.
… and most thoroughly investigated for adalimumab, etanercept, and ustekinumab. Hereafter, …
… and most thoroughly investigated for adalimumab, etanercept, and ustekinumab. Hereafter, …